TENAX THERAPEUTICS INC TENX
COM NEW · Common Stock · CUSIP 88032L605
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersChapel Hill, NC
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 6.2m as of 2025-11-11, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $12.19.
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2024 | 10 |
| Q2 2024 | 12 |
| Q3 2024 | 20 |
| Q4 2024 | 22 |
| Q1 2025 | 24 |
| Q2 2025 | 27 |
| Q3 2025 | 34 |
| Q4 2025 | 49 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2024 | 6 | 3 |
| Q3 2024 | 15 | 5 |
| Q4 2024 | 7 | 8 |
| Q1 2025 | 9 | 5 |
| Q2 2025 | 9 | 4 |
| Q3 2025 | 20 | 5 |
| Q4 2025 | 30 | 8 |
Biggest buyers
| PERCEPTIVE ADVISORS LLC | New | +439.1k |
| Point72 Asset Management, L.P. | New | +423.4k |
| MORGAN STANLEY | Added | +418.0k |
| DIADEMA PARTNERS LP | New | +243.2k |
| SPHERA FUNDS MANAGEMENT LTD. | New | +190.1k |
| FMR LLC | New | +141.1k |
| MARSHALL WACE, LLP | Added | +120.9k |
| VANGUARD GROUP INC | Added | +93.9k |
| CITADEL ADVISORS LLC | Added | +86.3k |
| Siren, L.L.C. | Added | +74.7k |
Biggest sellers
| Venrock Adviser, LLC | Sold out | -437.7k |
| Virtu Financial LLC | Sold out | -12.1k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -11.2k |
| DRW Securities, LLC | Sold out | -10.5k |
| Tower Research Capital LLC (TRC) | Reduced | -302 |
| SBI Securities Co., Ltd. | Sold out | -2 |
| Wealthspire Advisors, LLC | Sold out | -1 |
| Rockefeller Capital Management L.P. | Reduced | -1 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| ADAR1 Capital Management, LLC 13G · institution new · filed 2026-09-08 | 14.0% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor no change · filed 2026-08-14 | 10.0% |
| JANUS HENDERSON GROUP PLC 13G · institution +6.0 pts · filed 2025-12-08 | 10.0% |
| RTW INVESTMENTS, LP 13G · institution no change · filed 2026-08-14 | 9.9% |
| Vestal Point Capital, LP 13G · institution new · filed 2025-11-14 | 9.9% |
| Vivo Opportunity Fund Holdings, L.P. 13G · passive investor filed 2026-08-14 | 9.0% |
| BlackRock, Inc. 13G · institution +1.1 pts · filed 2026-10-27 | 7.5% |
| SPHERA FUNDS MANAGEMENT LTD. 13G · passive investor +1.8 pts · filed 2026-10-13 | 7.1% |
| Adage Capital Management, L.P. 13G · institution filed 2026-08-12 | 6.8% |
| Dellora Investments LP 13G · passive investor +4.1 pts · filed 2026-10-09 | 6.4% |
Fell to 5% or below in the last year: MILLENNIUM MANAGEMENT LLC (3.6%, 2026-10-15), ING GROEP NV (0.0%, 2026-09-11), FMR LLC (1.4%, 2026-09-08), PERCEPTIVE ADVISORS LLC (4.5%, 2026-08-14), Venrock Healthcare Capital Partners III, L.P. (4.7%, 2026-08-14), Ikarian Capital, LLC (2.9%, 2026-08-14), Giordano Christopher Thomas (4.3%, 2026-07-31), PRICE T ROWE ASSOCIATES INC /MD/ (2.2%, 2026-06-05), Stonepine Capital Management, LLC (3.7%, 2026-05-15), Point72 Asset Management, L.P. (3.1%, 2026-05-15)
Insider purchases and sales in Q4 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 2 | — | 0 | — | — |
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 0 | — | — |
| Q4 2025 | 4 | $189.6k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-12-09 | Rich Stuart Chief Medical Officer, director | Bought | $25.6k2.5k shares |
| 2025-12-08 | Rich Stuart Chief Medical Officer, director · By Stuart Rich Revocable Trust DTD 11/18/1996 | Bought | $25.2k2.5k shares |
| 2025-12-04 | Rich Stuart Chief Medical Officer, director | Bought | $23.0k2.5k shares |
| 2025-12-03 | Rich Stuart Chief Medical Officer, director | Bought | $13.6k1.5k shares |
| 2025-12-02 | Rich Stuart Chief Medical Officer, director | Bought | $9.0k1.0k shares |
| 2025-11-20 | Giordano Christopher Thomas CEO, director | Bought | $4.1k538 shares |
| 2025-11-19 | Giordano Christopher Thomas CEO, director | Bought | $3.4k455 shares |
| 2025-11-18 | Almenoff June Sherie Director · By Meadowlark Management, LLC | Bought | $14.3k1.9k shares |
| 2025-11-18 | Giordano Christopher Thomas CEO, director | Bought | $12.5k1.6k shares |
| 2025-11-17 | MCGAULEY THOMAS Interim CFO | Bought | $36.1k5.0k shares |
| 2025-11-17 | MCGAULEY THOMAS Interim CFO | Bought | $14.7k2.0k shares |
| 2025-11-17 | MCGAULEY THOMAS Interim CFO · By Spouse | Bought | $7.3k1.0k shares |
| 2025-11-17 | Almenoff June Sherie Director · By Meadowlark Management, LLC | Bought | $66593 shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q4 2025
| Manager | Shares | Change |
|---|---|---|
| Ikarian Capital, LLC 1.53% of their portfolio | 967.6k $11.8m | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 596.4k $7.3m | Added +418.0k |
| PERCEPTIVE ADVISORS LLC 0.10% of their portfolio | 439.1k $5.4m | New |
| Siren, L.L.C. 0.16% of their portfolio | 427.1k $5.2m | Added +74.7k |
| Point72 Asset Management, L.P. 0.01% of their portfolio | 423.4k $5.2m | New |
| RTW INVESTMENTS, LP 0.05% of their portfolio | 378.3k $4.6m | Unchanged |
| BOOTHBAY FUND MANAGEMENT, LLC 0.11% of their portfolio | 352.2k $4.3m | Unchanged |
| BVF INC/IL 0.14% of their portfolio | 339.5k $4.1m | Unchanged |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 302.5k $3.7m | Reduced -11.2k |
| MARSHALL WACE, LLP 0.00% of their portfolio | 298.2k $3.6m | Added +120.9k |
| VANGUARD GROUP INC 0.00% of their portfolio | 255.7k $3.1m | Added +93.9k |
| DIADEMA PARTNERS LP 1.77% of their portfolio | 243.2k $3.0m | New |
| Vivo Capital, LLC 0.16% of their portfolio | 208.3k $2.5m | Unchanged |
| SPHERA FUNDS MANAGEMENT LTD. 0.48% of their portfolio | 190.1k $2.3m | New |
| Integral Health Asset Management, LLC 0.10% of their portfolio | 167.0k $2.0m | Unchanged |
| JANUS HENDERSON GROUP PLC 0.00% of their portfolio | 166.7k $2.0m | Unchanged |
| Woodline Partners LP 0.01% of their portfolio | 143.5k $1.7m | Added +55.3k |
| FMR LLC 0.00% of their portfolio | 141.1k $1.7m | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 129.5k $1.6m | Added +86.3k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 125.6k $1.5m | Added +69.0k |
| Deeter Investments LLP 0.26% of their portfolio | 100.0k $1.2m | First filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.00% of their portfolio | 83.3k $1.0m | Unchanged |
| Velan Capital Investment Management LP 0.59% of their portfolio | 83.3k $1.0m | Unchanged |
| Persistent Asset Partners Ltd 0.38% of their portfolio | 65.3k $795.7k | New |
| ADAR1 Capital Management, LLC 0.06% of their portfolio | 63.7k $776.2k | Added +10.2k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 55.7k $679.0k | Added +21.3k |
| Vestal Point Capital, LP 0.02% of their portfolio | 53.4k $651.4k | Unchanged |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 44.9k $547.3k | New |
| Artia Global Partners LP 0.08% of their portfolio | 42.1k $513.0k | New |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 33.5k $408.0k | New |
| Corient Private Wealth LP 0.00% of their portfolio | 24.8k $302.0k | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 22.4k $273.2k | New |
| Quadrature Capital Ltd 0.00% of their portfolio | 20.6k $251.7k | New |
| BlackRock, Inc. 0.00% of their portfolio | 16.7k $203.7k | Added +16.4k |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 15.3k $186.5k | New |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 13.2k $160.6k | New |
| Stonepine Capital Management, LLC 0.11% of their portfolio | 11.9k $144.9k | New |
| LETKO, BROSSEAU & ASSOCIATES INC 0.00% of their portfolio | 10.7k $129.8k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 3.8k $46.1k | Added +3.5k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 902 $11.0k | New |
| UBS Group AG 0.00% of their portfolio | 676 $8.2k | Added +557 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 199 $2.4k | Reduced -302 |
| JONES FINANCIAL COMPANIES LLLP 0.00% of their portfolio | 1 $12 | Unchanged |
| CITIGROUP INC 0.00% of their portfolio | 1 $12 | New |
| Allworth Financial LP 0.00% of their portfolio | 1 $13 | Unchanged |
| Union Bancaire Privee, UBP SA 0.00% of their portfolio | 1 $9 | Unchanged |
| Rockefeller Capital Management L.P. 0.00% of their portfolio | 1 $12 | Reduced -1 |
| Physician Wealth Advisors, Inc. 0.00% of their portfolio | 1 $13 | Unchanged |
| Titiun Yejiel 0.00% of their portfolio | 1 $12 | First filing |